FDA IX Basulta

10/07/2026

****FDA Advisory No.2026-0780 || FOOD AND DRUG ACTION CENTER'S ADDITIONAL TELEPHONE NUMBERS****

The Food and Drug Action Center (FDAC) informs all FDA stakeholders and the general public that effective 15 July 2026, an additional official contact numbers will be made available to further address inquiries and concerns related to health product and establishment regulations and services of the Food and Drug Administration (FDA).

Existing Contact Numbers:

(02) 8257-1957

(02) 8273-0481

(02) 8273-3756

(02) 8286-6087

(02) 8800-4392

(02) 8659-7330

New Additional Contact Numbers:

0277090151 (using mobile telephone)

770090151 (using direct landline)

This new contact numbers supplement the existing FDA contact numbers and provide the necessary channels for communication with the FDAC. All previously published telephone numbers remain active and may continue to be used.

Read more:-> https://tinyurl.com/4btbswtt

****FDA Advisory No.2026-0780 || FOOD AND DRUG ACTION CENTER'S ADDITIONAL TELEPHONE NUMBERS****

The Food and Drug Action Center (FDAC) informs all FDA stakeholders and the general public that effective 15 July 2026, an additional official contact numbers will be made available to further address inquiries and concerns related to health product and establishment regulations and services of the Food and Drug Administration (FDA).

Existing Contact Numbers:

(02) 8257-1957

(02) 8273-0481

(02) 8273-3756

(02) 8286-6087

(02) 8800-4392

(02) 8659-7330

New Additional Contact Numbers:

0277090151 (using mobile telephone)

770090151 (using direct landline)

This new contact numbers supplement the existing FDA contact numbers and provide the necessary channels for communication with the FDAC. All previously published telephone numbers remain active and may continue to be used.

Read more:-> https://tinyurl.com/2mshkjb6

25/06/2026

***Department Circular No.2026-0329 || ALL UNDERSECRETARIES AND ASSISTANT SECRETARIES; DIRECTORS OF BUREAUS, SERVICES, AND CENTERS FOR HEALTH DEVELOPMENT: MINISTER OF HEALTH BANGSAMORO AUTONOMOUS REGION IN MUSLIM MINDANAO (MOH-BARMM); EXECUTIVE DIRECTORS OF SPECIALTY HOSPITALS; CHIEFS OF DOH-RETAINED HOSPITALS, MEDICAL CENTERS, SANITARIA, INSTITUTES; PRIVATE HOSPITALS, LOCAL GOVERNMENT UNITS, FDA STAKEHOLDERS AND CLIENTS, AND ALL OTHERS CONCERNED***

Read more:-> https://tinyurl.com/37xjmta4

***Department Circular No.2026-0329 || Further Extension of the Temporary Suspension of the Implementation of Administrative Order No. 2024-0016 entitled, "Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration" and its Amendments, Pursuant to Executive Order No. 110, entitled "Declaring a State of National Energy Emergency and Authorizing the Unified Package for Livelihood, Industry, Food, and Transport"***

Read more:-> https://tinyurl.com/37xjmta4

13/05/2026

The Department of Health – Zamboanga Peninsula Center for Health Development (DOH-ZPCHD) formally congratulates 𝐃𝐢𝐫. 𝐒𝐡𝐚𝐫𝐨𝐧 𝐑𝐨𝐬𝐞 𝐏. 𝐆𝐚𝐫𝐜𝐢𝐚, 𝐌𝐒𝐜, on her appointment as 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫 𝐈𝐈 𝐨𝐟 𝐭𝐡𝐞 𝐅𝐨𝐨𝐝 𝐚𝐧𝐝 𝐃𝐫𝐮𝐠 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 – 𝐌𝐢𝐧𝐝𝐚𝐧𝐚𝐨 𝐖𝐞𝐬𝐭 𝐂𝐥𝐮𝐬𝐭𝐞𝐫, 𝐅𝐢𝐞𝐥𝐝 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐎𝐟𝐟𝐢𝐜𝐞.

This well-deserved promotion is a testament to your hard work and commitment to excellence in public service. We wish you continued success in this new chapter of your leadership.

13/05/2026

***Announcement || NOTICE ON THE DISCONTINUATION OF BANCNET ONLINE FACILITY***

Please be informed that BancNet Online (BOL) services have been discontinued effective 01 July 2024. This includes:

● balance inquiry, bills payment,
● fund transfer,
● and e‑shopping transactions coursed through BancNet Online.

See more:-> https://tinyurl.com/34y2bhdj

02/02/2026

****Announcement || FDA ACADEMY TRAINING CALENDAR THROUGH ONLINE PLATFORM FOR THE 1ST SEMESTER OF CY 2026****

The Policy and Planning Office – FDA Academy hereby announces the following seminar and training offerings for the First Semester of Calendar Year 2026, to be conducted through an online video-conferencing platform. Additional programs may be included as deemed necessary.

See more:-> https://tinyurl.com/ynuhue8u

22/01/2026

⚠️ Public Advisory: Beware of fixers and unauthorized individuals claiming to represent the FDA. All FDA transactions must go through official channels only. Let’s help protect public health by staying informed and reporting illegal activities.

𝐏𝐔𝐁𝐋𝐈𝐂 𝐖𝐀𝐑𝐍𝐈𝐍𝐆 𝐀𝐆𝐀𝐈𝐍𝐒𝐓 𝐔𝐍𝐀𝐔𝐓𝐇𝐎𝐑𝐈𝐙𝐄𝐃 𝐅𝐃𝐀-𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐑𝐀𝐍𝐒𝐀𝐂𝐓𝐈𝐎𝐍𝐒 𝐀𝐍𝐃 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒

The Food and Drug Administration (FDA) warns the public and regulated establishments against individuals who falsely represent themselves as FDA officers, employees, or accredited consultants and who solicit money in exchange for the facilitation, expediting, or guarantee of FDA approvals or regulatory actions.

The FDA does not authorize any individual or private entity to collect payments or offer services on its behalf. All FDA applications and transactions are processed only through official FDA offices and platforms, in strict accordance with existing laws, rules, regulations, and the FDA Citizen’s Charter. Any transaction outside these official channels is UNAUTHORIZED and ILLEGAL.

The FDA emphasizes that regulatory decisions are and will be based solely on completeness and compliance with safety, quality, and efficacy standards.

The public is strongly encouraged to report fixers, unauthorized consultants, or any individual who solicits payments in connection with FDA transactions. Reports may be made through the Food and Drug Action Center (FDAC) via its official hotlines at (02) 8257-1957, (02) 8286-6087, (02) 8273-048, (02) 8800-4392, (02) 8273-3756, and (02) 8659-7330, or through email at [email protected] or [email protected].

The FDA remains committed to integrity, transparency, and accountability in protecting public health.

18/12/2025

🚨 WE'RE HIRING! 🚨

Join our team at Food and Drug Administration IX and XII! We’re looking for passionate and skilled individuals to fill the position(s):

📍 Location: Regional Field Office IX
📌 Food-Drug Regulation Officer II (GDP Section)
📌 Item Number: OSEC-DOHB-FDRO2-570003-1998
🔹 Education: Bachelor's Degree in Pharmacist/Industrial Pharmacy
✨ Eligibility: CS Professional or Republic Act (RA) 1080

📍 Location: Regional Field Office XII
📌 Food-Drug Regulation Officer II (Food Section)
📌 Item Number: OSEC-DOHB-FDRO2-570007-1998
🔹 Education: Bachelor's Degree in Food Technology
✨ Eligibility: CS Professional or Republic Act (RA) 1080

📅 Deadline: 25 December 2025

Interested and qualified applicants shall answer the questions in this form (bit.ly/3KRS9Fm) and attach the necessary documents for initial documentary review and evaluation. Applications with incomplete documents shall not be entertained.

24/11/2025

📢 We're Hiring!

The Food and Drug Administration – Center for Drug Regulation and Research is in need of the following personnel:

👉🏻 (72) Food-Drug Regulation Officer I - Licensing and Registration Division

Interested and qualified applicants are advised to submit the following requirements through this link: https://tinyurl.com/Apply-CDRR-FDRO1

Applicants are encouraged to visit the FDA Careers Webpage (https://www.fda.gov.ph/careers/) for further information.

Requirements:https://www.fda.gov.ph/wp-content/uploads/2025/11/CDRR-FDRO1.pdf

📅 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞 𝐨𝐟 𝐒𝐮𝐛𝐦𝐢𝐬𝐬𝐢𝐨𝐧: 27 November 2025, Thursday

19/11/2025

🚨 WE'RE HIRING! 🚨
📌 (2) ADMINISTRATIVE AIDE VI (CHAFFEUR II REGION IX and REGION XII)
PAY RATE: SG-6 (Php18, 957.00/month) w/ 20% Premium

Join our team at Food and Drug Administration IX! We’re looking for passionate and skilled individuals to fill the position(s):

🔹 Education: Elementary School Graduate
✨ Eligibility: Professional Driver's license (MC No. 10, s. 2013-Cat. IV)
📍 Location:

RFO IX: 3rd Floor, Prime Arcade Bldg., National Highway, Tiguma, Pagadian City

RFO XII: Prime Regional Field Office XII, Brgy.
Carpenter Hill, Koronadal City, South Cotabato
📅 Deadline: 25 November 2025

Interested and qualified applicants shall answer the questions in this form (https://bit.ly/44j7wwN) and attach the necessary documents for initial documentary review and evaluation. Applications with incomplete documents shall not be entertained.